A phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group study of 5% sofpironium bromide (BBI‐4000) gel in Japanese patients with primary axillary hyperhidrosis

The Journal of Dermatology ◽

10.1111/1346-8138.15668 ◽

2021 ◽

Author(s):

Hiroo Yokozeki ◽

Tomoko Fujimoto ◽

Yoichiro Abe ◽

Masaru Igarashi ◽

Akiko Ishikoh ◽

...

Keyword(s):

Japanese Patients ◽

Axillary Hyperhidrosis ◽

Phase 3 ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study

Sleep Medicine ◽

10.1016/j.sleep.2013.07.007 ◽

2013 ◽

Vol 14 (11) ◽

pp. 1085-1091 ◽

Author(s):

Yuichi Inoue ◽

Tetsuo Shimizu ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Jun Ishigooka ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Restless Legs ◽

Parallel Group Study ◽

Download Full-text

A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation

Journal of Cystic Fibrosis ◽

10.1016/j.jcf.2020.11.003 ◽

2020 ◽

Author(s):

Edward F. McKone ◽

Emily A. DiMango ◽

Sivagurunathan Sutharsan ◽

Tara Lynn Barto ◽

Daniel Campbell ◽

...

Keyword(s):

Cystic Fibrosis ◽

Phase 3 ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Is benzoyl peroxide 3% topical gel effective and safe in the treatment of acne vulgaris in Japanese patients? A multicenter, randomized, double-blind, vehicle-controlled, parallel-group study

The Journal of Dermatology ◽

10.1111/1346-8138.12580 ◽

2014 ◽

Vol 41 (9) ◽

pp. 795-801 ◽

Author(s):

Makoto Kawashima ◽

Hirofumi Hashimoto ◽

Alessandra B. Alio Sáenz ◽

Makoto Ono ◽

Masahiro Yamada

Keyword(s):

Benzoyl Peroxide ◽

Acne Vulgaris ◽

Japanese Patients ◽

Double Blind ◽

Topical Gel ◽

Parallel Group Study ◽

Download Full-text

Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.02.015 ◽

2012 ◽

Vol 34 (4) ◽

pp. 838-848 ◽

Author(s):

Hiromi Rakugi ◽

Toshio Ogihara ◽

Yuko Miyata ◽

Kiyofumi Sasai ◽

Nobuo Totsuka

Keyword(s):

Essential Hypertension ◽

Combination Therapy ◽

Candesartan Cilexetil ◽

Japanese Patients ◽

Moderate Essential Hypertension ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma

Advances in Therapy ◽

10.1007/s12325-018-0702-4 ◽

2018 ◽

Vol 35 (5) ◽

pp. 737-748 ◽

Author(s):

William W. Busse ◽

Jorge F. Maspero ◽

Klaus F. Rabe ◽

Alberto Papi ◽

Sally E. Wenzel ◽

...

Keyword(s):

Severe Asthma ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study

Current Medical Research and Opinion ◽

10.1185/03007995.2012.746217 ◽

2012 ◽

Vol 29 (1) ◽

pp. 13-21 ◽

Author(s):

Yuichi Inoue ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Kenji Kuroda ◽

Nobutaka Hattori ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Gabapentin Enacarbil ◽

Double Blind ◽

Double Blind Placebo ◽

Restless Legs ◽

Parallel Group Study ◽

Download Full-text

Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double‐blind, double‐dummy, active‐controlled, parallel‐group study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12391 ◽

2016 ◽

Vol 41 (3) ◽

pp. 290-297 ◽

Author(s):

T. Hosoya ◽

Y. Ogawa ◽

H. Hashimoto ◽

T. Ohashi ◽

R. Sakamoto

Keyword(s):

Phase 3 ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text

Tapentadol immediate-release for acute postbunionectomy pain: a phase 3, randomized, double-blind, placebo-controlled, parallel-group study in Taiwan

Current Medical Research and Opinion ◽

10.1185/03007995.2015.1082992 ◽

2015 ◽

Vol 31 (11) ◽

pp. 2001-2009 ◽

Author(s):

Yeung-Jen Chen ◽

Chao-Ching Chiang ◽

Peng-Ju Huang ◽

Jason Huang ◽

Keith Karcher ◽

...

Keyword(s):

Immediate Release ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis

Journal of Bone and Mineral Metabolism ◽

10.1007/s00774-019-01031-x ◽

2019 ◽

Vol 38 (1) ◽

pp. 86-98

Author(s):

Satoshi Soen ◽

Hideaki Kishimoto ◽

Hiroshi Hagino ◽

Teruki Sone ◽

Hiroaki Ohishi ◽

...

Keyword(s):

Phase Ii ◽

Japanese Patients ◽

Immediate Release ◽

Double Blind ◽

Involutional Osteoporosis ◽

Delayed Release ◽

Parallel Group Study ◽

Download Full-text

A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation

Journal of Cystic Fibrosis ◽

10.1016/j.jcf.2020.07.023 ◽

2020 ◽

Author(s):

Jane C. Davies ◽

Isabelle Sermet-Gaudelus ◽

Lutz Naehrlich ◽

R. Scott Harris ◽

Daniel Campbell ◽

...

Keyword(s):

Cystic Fibrosis ◽

Efficacy And Safety ◽

Residual Function ◽

Phase 3 ◽

Double Blind ◽

Parallel Group Study ◽

Download Full-text